To further strengthen Pharmacosmos overall growth, we are now searching for a Head of Global Business Development reporting directly to Chief Operating Officer, Tobias Christensen.
The position, which is based at Headquarters in Holbæk, is an exciting role involving close collaboration with the senior management of Pharmacosmos to expand and optimise Pharmacosmos’ portfolio.
The role will cover and include project ownership in all areas of business development:
In each case, the candidate’s responsibility will cover all aspects of business development projects from scouting, project setup, and execution.
The candidate will coordinate project evaluations propose coordination and execution in close collaboration with our Chief Medical Officer / VP of R&D, our VP responsible for affiliates, and key functions including medical affairs, regulatory, and business support staff.
The candidate will have the experience and capacity to act as the principal negotiator or as a negotiation team member depending on the need.
Pharmacosmos offers an exciting and challenging job in an active work environment where there is a “high ceiling” and where well-being and job satisfaction are in focus. The right candidate will have the best personal and professional growth conditions in a dynamic organisation, prioritising employees’ development.
If you enjoy delivering ambitious results in a challenging business environment, being part of a dynamic team with double-digit growth ambitions, then this might be the position you are looking for.
Up to 50 days per year
Salary and benefits
To be negotiated individually.
If you have any questions or want to apply for this job, please contact:
Mobile: +45 2920 3265
CV and application should be in English.
The job is located in Holbæk, Sjælland.
Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.
Pharmacosmos has subsidiaries in US, China, UK, Ireland, Germany, Sweden and Norway and its products are marketed in more than 80 countries around the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.
Vi takker for din henvendelse og vender tilbage til dig hurtigst muligt
You are now leaving Pharmacosmos.com. The website you are about to visit is is a Pharmacosmos subsidary. Do you want to proceed?